vs
APOGEE ENTERPRISES, INC.（APOG）与GE医疗（CCRN）财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是GE医疗的1.5倍（$351.4M vs $236.8M），APOGEE ENTERPRISES, INC.净利率更高（4.7% vs -35.0%，领先39.8%），APOGEE ENTERPRISES, INC.同比增速更快（1.6% vs -23.6%），过去两年APOGEE ENTERPRISES, INC.的营收复合增速更高（2.9% vs -21.0%）
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
APOG vs CCRN — 直观对比
营收规模更大
APOG
是对方的1.5倍
$236.8M
营收增速更快
APOG
高出25.2%
-23.6%
净利率更高
APOG
高出39.8%
-35.0%
两年增速更快
APOG
近两年复合增速
-21.0%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $351.4M | $236.8M |
| 净利润 | $16.6M | $-82.9M |
| 毛利率 | 22.4% | — |
| 营业利润率 | 7.3% | -30.2% |
| 净利率 | 4.7% | -35.0% |
| 营收同比 | 1.6% | -23.6% |
| 净利润同比 | 568.8% | -2109.7% |
| 每股收益（稀释后） | $0.78 | $-2.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APOGCCRN
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $236.8M | ||
| Q3 25 | $358.2M | $250.1M | ||
| Q2 25 | $346.6M | $274.1M | ||
| Q1 25 | $345.7M | $293.4M | ||
| Q4 24 | $341.3M | $309.9M | ||
| Q3 24 | $342.4M | $315.1M | ||
| Q2 24 | $331.5M | $339.8M |
净利润APOGCCRN
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-82.9M | ||
| Q3 25 | $23.6M | $-4.8M | ||
| Q2 25 | $-2.7M | $-6.7M | ||
| Q1 25 | $2.5M | $-490.0K | ||
| Q4 24 | $21.0M | $-3.8M | ||
| Q3 24 | $30.6M | $2.6M | ||
| Q2 24 | $31.0M | $-16.1M |
毛利率APOGCCRN
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | 20.4% | ||
| Q2 25 | 21.7% | 20.4% | ||
| Q1 25 | 21.6% | 20.0% | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | 20.4% | ||
| Q2 24 | 29.8% | 20.8% |
营业利润率APOGCCRN
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | -30.2% | ||
| Q3 25 | 7.5% | -2.4% | ||
| Q2 25 | 2.0% | -2.1% | ||
| Q1 25 | 1.8% | -0.3% | ||
| Q4 24 | 8.4% | -1.1% | ||
| Q3 24 | 12.3% | 0.9% | ||
| Q2 24 | 12.5% | -5.7% |
净利率APOGCCRN
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -35.0% | ||
| Q3 25 | 6.6% | -1.9% | ||
| Q2 25 | -0.8% | -2.4% | ||
| Q1 25 | 0.7% | -0.2% | ||
| Q4 24 | 6.1% | -1.2% | ||
| Q3 24 | 8.9% | 0.8% | ||
| Q2 24 | 9.4% | -4.7% |
每股收益（稀释后）APOGCCRN
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-2.56 | ||
| Q3 25 | $1.10 | $-0.15 | ||
| Q2 25 | $-0.13 | $-0.20 | ||
| Q1 25 | $0.12 | $-0.02 | ||
| Q4 24 | $0.96 | $-0.13 | ||
| Q3 24 | $1.40 | $0.08 | ||
| Q2 24 | $1.41 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $108.7M |
| 总债务越低越好 | $232.3M | — |
| 股东权益账面价值 | $511.8M | $322.8M |
| 总资产 | $1.1B | $449.0M |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资APOGCCRN
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $108.7M | ||
| Q3 25 | $39.5M | $99.1M | ||
| Q2 25 | $32.8M | $81.2M | ||
| Q1 25 | $41.4M | $80.7M | ||
| Q4 24 | $43.9M | $81.6M | ||
| Q3 24 | $51.0M | $64.0M | ||
| Q2 24 | $30.4M | $69.6M |
总债务APOGCCRN
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APOGCCRN
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $322.8M | ||
| Q3 25 | $500.2M | $408.1M | ||
| Q2 25 | $481.8M | $412.2M | ||
| Q1 25 | $487.9M | $418.2M | ||
| Q4 24 | $522.1M | $419.0M | ||
| Q3 24 | $506.4M | $424.7M | ||
| Q2 24 | $480.0M | $433.3M |
总资产APOGCCRN
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $449.0M | ||
| Q3 25 | $1.2B | $538.2M | ||
| Q2 25 | $1.2B | $553.8M | ||
| Q1 25 | $1.2B | $576.2M | ||
| Q4 24 | $1.2B | $589.3M | ||
| Q3 24 | $917.1M | $597.4M | ||
| Q2 24 | $889.0M | $602.9M |
负债/权益比APOGCCRN
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $122.5M | $18.2M |
| 自由现金流经营现金流 - 资本支出 | — | $16.1M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | 7.8% | 0.9% |
| 现金转化率经营现金流/净利润 | 7.37× | — |
| 过去12个月自由现金流最近4个季度 | — | $40.1M |
8季度趋势，按日历期对齐
经营现金流APOGCCRN
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $18.2M | ||
| Q3 25 | $57.1M | $20.1M | ||
| Q2 25 | $-19.8M | $4.2M | ||
| Q1 25 | $30.0M | $5.7M | ||
| Q4 24 | $31.0M | $24.2M | ||
| Q3 24 | $58.7M | $7.5M | ||
| Q2 24 | $5.5M | $82.4M |
自由现金流APOGCCRN
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $16.1M | ||
| Q3 25 | $52.4M | $17.9M | ||
| Q2 25 | $-26.9M | $2.3M | ||
| Q1 25 | $19.1M | $3.8M | ||
| Q4 24 | $22.0M | $21.7M | ||
| Q3 24 | $50.2M | $6.3M | ||
| Q2 24 | $-1.8M | $79.6M |
自由现金流率APOGCCRN
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 6.8% | ||
| Q3 25 | 14.6% | 7.2% | ||
| Q2 25 | -7.8% | 0.8% | ||
| Q1 25 | 5.5% | 1.3% | ||
| Q4 24 | 6.4% | 7.0% | ||
| Q3 24 | 14.7% | 2.0% | ||
| Q2 24 | -0.5% | 23.4% |
资本支出强度APOGCCRN
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 0.9% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 2.1% | 0.7% | ||
| Q1 25 | 3.2% | 0.6% | ||
| Q4 24 | 2.6% | 0.8% | ||
| Q3 24 | 2.5% | 0.4% | ||
| Q2 24 | 2.2% | 0.8% |
现金转化率APOGCCRN
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | 2.92× | ||
| Q2 24 | 0.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
